Incubation period of Creutzfeldt–Jakob disease in human growth hormone recipients in France
暂无分享,去创建一个
Y. Agid | J. Hauw | A. Alpérovitch | D. Costagliola | D. Dormont | J. Chaussain | J. Brandel | T. D. de Villemeur | J. Maccario | J. Deslys | J. H. D'Aignaux
[1] C. Tribioli,et al. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL , 1998, Nature Genetics.
[2] J. Laplanche,et al. Molecular genetics of prion diseases in France , 1994, Neurology.
[3] Andrew F. Hill,et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.
[4] A. Hofman,et al. A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.
[5] L. Billard,et al. Incubation period of AIDS in patients infected via blood transfusion , 1987, Nature.
[6] S. Cousens,et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.
[7] Y. Agid,et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France , 1996, Neurology.
[8] D. Wysowski,et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. , 1991, JAMA.
[9] P. Brown,et al. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease , 1992, The Lancet.
[10] A. Alpérovitch,et al. A Stastical Model to Identify the contaminated Lots Implicated in Latrogenic Transmision of Creutzfeldt-Jakob Disease among French Human Growth Hoermone Receipents , 1998 .
[11] J J Goedert,et al. Censoring in an epidemic with an application to hemophilia-associated AIDS. , 1989, Biometrics.
[12] M. Palmer,et al. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease , 1991, The Lancet.
[13] D. Costagliola,et al. Incubation time for AIDS from French transfusion-associated cases , 1989, Nature.
[14] R. G. Will,et al. Predicting the CJD epidemic in humans , 1997, Nature.